Following the release of the second medium term plan for Vision 2030 covering the period 2013-2017, it is now possible to discern the Kenyan Government’s strategy insofar as access to medicines is concerned.
Under its social pillar, HIV/AIDS has been identified as a major health challenge. The aim of the government is to work towards reducing the HIV/AIDS prevalence rate to 4% come 2017 from 5.6% in 2012.
In this regard, one of the flagship projects to be prioritized in the coming years is the health products and technologies. In this project, the government is committing to promote local production, research and innovation of essential health products and technologies.
In addition, the government has proposed a raft of policy, legal and institutional reforms. Notably, the government has outlined the need to develop policies to guide and encourage local manufacture to produce drugs and commodities locally.